
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1195765-47-9 |
| Catalog No. | 2A-3179613 |
| Chinese Name | Desmethyl dabrafenib |
| Synonyms | UNII-3EHQ1EWE0D; Desmethyl dabrafenib; Dabrafenib metabolite M8 |
| Molecular Formula | C22H18F3N5O2S2 |
| Molecular Weight | 505.53600 |
| PubChem ID | 138603321 |
| SMILES | CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1 |
| InChI | InChI=1S/C22H18F3N5O2S2/c1-11(2)21-29-18(19(33-21)16-9-10-27-22(26)28-16)12-5-3-8-15(17(12)25)30-34(31,32)20-13(23)6-4-7-14(20)24/h3-11,30H,1-2H3,(H2,26,27,28) |
| InChI Key | MQEHPCURISZMGR-UHFFFAOYSA-N |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Clarithromycin (9Z)-Oxime | 127253-05-8 | 2A-3179584 |
| N-Desmethyl Clarithromycin (9E)-Oxime | 127182-43-8 | 2A-3179585 |
| (10E)-10,11-Didehydro-11-deoxy-6-O-MethylerythroMycin | 144604-03-5 | 2A-3179586 |
| 3-chloroRivaroxaban | 1855920-54-5 | 2A-3179597 |
| Sunitinib N-Oxide | 356068-99-0 | 2A-3179612 |
| Dabrafenib Hydroxy | 1195767-77-1 | 2A-3179614 |
| Dabrafenib Carboxylic Acid | 1195873-54-1 | 2A-3179615 |
| α-Capecitabine | 2230479-30-6 | 2A-3179616 |
| Capecitabinealfa alfa impurity2 | 1810778-34-7 | 2A-3179618 |
| LincoMycin 2-Phosphate | 27480-30-4 | 2A-3179636 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA